Skip to main content



Growth hormone (GH) controls the growth of soft tissue and bone. Elevated GH causes an excess of bone and soft tissue growth. In adults, this can cause a rare disorder called acromegaly. It can cause serious complications and early death if not treated.

In young children, bone growth is still occurring. Excess GH can cause a similar condition called gigantism. Gigantism causes dramatic growth in children.


The pituitary gland is a small gland located at the base of the brain. It produces many hormones, including GH.

In most cases, the elevation of GH is caused by a benign tumor of this gland. In a small number of cases, cancerous tumors of other organs, such as the pancreas, adrenal, or lung, may be the source of excess GH.

Pituitary Gland
Nucleus factsheet image
Copyright © Nucleus Medical Media, Inc.

Risk Factors

Acromegaly is more common in people who are aged 40-45 years. Family history of acromegaly may rarely increase your risk of this condition.


Symptoms usually develop slowly over time.

In children, the bones are longer and cause soft tissue swelling. If not treated, children can grow to a height of 7-8 feet.

Symptoms and complications in adults may include:

  • Abnormally large growth and deformity of the:
    • Hands—rings no longer fit
    • Feet—need a bigger size shoe
    • Face—bulging of brow and lower jaw
    • Jaw—teeth do not line up correctly when the mouth is closed
    • Lips
    • Tongue
  • Skin changes, such as:
    • Thickened, oily, and sometimes darkened skin
    • Severe acne
    • Excessive sweating and unpleasant body order due to enlargement of the sweat glands
  • Deepening voice due to enlarged sinuses, vocal cords, and soft tissues of the throat
  • Difficulty sleeping due to a blocked airway
  • Swelling in the neck
  • Fatigue and weakness in the legs and arms
  • Joint pain, especially in the jaw
  • In women:
    • Irregular menstrual cycles
    • Abnormal production of breast milk
  • In men—inability to get or sustain an erection


You will be asked about your symptoms and medical history. A physical exam will be done. Acromegaly is often not diagnosed until years after it begins.

Your bodily fluids may be tested. This can be done with blood tests.

Images may be taken of your bodily structures. This can be done with:


The goals of treatment are to:

  • Reduce production of GH to normal levels
  • Stop and reverse the symptoms caused by excess GH
  • Correct other endocrine abnormalities, such as thyroid, adrenal, and sex organs
  • Reduce tumor size

Treatment may include:


The tumor that is believed to be causing acromegaly may be removed. In most cases, this is the preferred treatment. However, drug treatment is increasing in popularity.

Radiation Therapy

In adults, external beams of radiation are used to shrink the tumor. It is most often used when surgery cannot be used or when medications have failed.


Medications may be given to:

  • Reduce the level of GH
  • Shrink the tumor before surgery


There are no current guidelines to prevent acromegaly. Early treatment will help to prevent serious complications.

Revision Information

  • National Institute of Diabetes & Digestive & Kidney Diseases

  • Pituitary Network Association

  • Canadian Society of Endocrinology and Metabolism

  • Health Canada

  • Abrams P, Alexopoulou O, et al. Optimalization and cost management of lanreotide-Autogel therapy in acromegaly. Eur J Endocrinol. 2007;571-577.

  • Acromegaly. EBSCO DynaMed website. Available at: Updated May 9, 2014. Accessed June 4, 2014.

  • Acromegaly treatment consensus workshop participants: guidelines for acromegaly management. J Clin Endocrinol Metab. 2002; 87:4054-4058.

  • Cook DM. AACE Acromegaly Guidelines Taskforce. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly. Endoc Pract. 2004;10:213-225.

  • Glustina A, Barkan A, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab. 2000;85:526-529.

  • Katznelson L, Atkinson JL, et al. American association of clinical endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of acromegaly - 2011 update: executive summary. Endocr Pract. 2011;17(4):636-646.

  • Melmed S. Medical progress: acromegaly. N Engl J Med. 2006;355:2558-2573.

  • Paisley AN, Trainer PJ. Medical treatment in acromegaly. Curr Opin Pharmacol. 2003;3:672-677.

  • Sherlock M, Woods C, Sheppard MC. Medical therapy in acromegaly. Nat Rev Endocrinol. 2011;7(5):291-300.

  • Trainer PJ, Drake WM, et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med. 2000; 342:1171-1177.

The health information in this Health Library is provided by a third party. TriStar Health does not in any way create the content of this information. It is provided solely for informational purposes. It does not constitute medical advice and is not intended to be a substitute for proper medical care provided by a physician. Always consult with your doctor for appropriate examinations, treatment, testing, and care recommendations. Do not rely on information on this site as a tool for self-diagnosis. If you have a medical emergency, call 911.